Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation

Kawamoto, Hiroyuki; Tanaka, Kentaro; Ruparelia, Neil; Takagi, Kensuke; Yabushita, Hiroto; Watanabe, Yûsuke; Mitomo, Satoru; Matsumoto, Takahiro; Naganuma, Toru; Fujino, Yusuke; Ishiguro, Hisaaki; Tahara, Satoko; Kurita, Naoyuki; Nakamura, Shotaro; Hozawa, Koji; Nakamura, Sunao

doi:10.1016/j.amjcard.2015.09.019

Cited by 44 publications

(53 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In contrast, our study reports more promising data with onlyone probable/possible stent thrombosis in each group (a total of 4%). These results are more in accordance with rates of 2% at 1 year reported by Kawamoto et al Late re‐endothelialization of CSs has been described as a potential mechanism of thrombogenicity . Remarkably, the fact that average DAPT duration remained high in both groups and the use of newer antiplatelet drugs could have favored this low rate of thrombosis.…”

Section: Discussionsupporting

confidence: 90%

“…In the contemporary series of CAP, the need for emergent surgical repair ranges from 13% to 16% and the in‐hospital mortality from 8% to 20% . These numbers are in agreement with prior publications on PTFE‐CS . In our cohort, rates of death and cardiac surgery were similar to those previously described among patients treated with PTFE‐CS.…”

Section: Discussionsupporting

confidence: 90%

“…Following CAP, long term outcomes are related with an increased mortality and MACE with rates ranging from 15% to 23% and 20‐40%, respectively . Our population presented higher rates of mortality and MACE than previously described.…”

Section: Discussionmentioning

confidence: 99%

“…PTFE‐CS were for years the most commonly available CSs in the interventional laboratories. Consequently, most of the results regarding CS performance are reported with this technology . In 2013, a PL‐CS obtained CE mark for treatment of CAP.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new‐generation covered stents

Hernández-Enrı́quez

Lairez

Campelo‐Parada

et al. 2018

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new‐generation covered stents

Hernández-Enrı́quez

Lairez

Campelo‐Parada

et al. 2018

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

“…PTFE‐covered stent is useful option as the bailout for coronary perforation and the percutaneous intervention for coronary artery aneurysm like this case . However, long‐term outcome, especially regarding target lesion revascularization, is not as good as that of the second generation drug eluting stent (DES) . While DCB has been known to be a useful therapeutic option for the treatment of DES restenosis, there are no available data about appropriate management for restenosis of PTFE‐covered stent.…”

Section: Discussionmentioning

confidence: 98%

Late lumen enlargement induced by drug coated balloon in the patient with PTFE‐covered stent restenosis

Warisawa

Naganuma

Nakamura

2017

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

We report a case of percutaneous coronary intervention with drug coated balloon (DCB) for the in-stent restenosis of polytetrafluoroethylene-covered stent. One year follow-up angiography was excellent and in-stent lumen enlargement compared with the postprocedure and 6-months follow-up was demonstrated by optical coherent tomography. This case suggested the utility of DCB as a therapeutic option for covered-stent restenosis.

show abstract

Acute and long‐term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3‐CAP registry

Pavani

Cerrato

Latib

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

Background: Covered stent (CS) implantation is considered a useful device in the setting of Grade III Coronary Perforation (G3CP), one of the most harmful PCI complication. However, data regarding efficacy of this device and clinical outcomes are still limited. Methods and results: From 1993 to 2015, among 97,779 patients from 9 European centres undergoing PCI, 224 patients had G3CP (0.23%), and 102 patients were managed with CS implantation (96 with PTFE, 6 with pericardium). Device oriented composite endpoint (DOCE), a composite of cardiac death, target lesion revascularization, and stent thrombosis (ST) in-hospital and at long term follow-up were evaluated. G3-CP perforations were successfully sealed with CS in 88 patients (86.3%) with need of intraprocedural pericardiocentesis in one-third of cases.Protamine as heparin reversal agent was administered in 36 (35%) of cases. The cumulative incidence of in-hospital DOCE were 16.6% (17/102): death 14.7%, TLR 2.9%, ST 3.9%. At longterm follow-up (mean 42 AE 38 months), DOCE rates occurred in 19.7%: death 7.4%, TLR 11%, and ST 6.2%. Indication to Dual Antiplatelet Therapy (DAPT) was lifelong in 20% of cases, 1 to 6 months in 22.5% and 12-months in 57.5% without differences in long-term DOCE before and after DAPT interruption (8.0 vs. 6.6%, respectively, P = 0.20).Conclusions: Use of CS was successful in sealing grade 3 coronary artery perforations in the majority of cases. Beside the high rate of clinical events at short and long-term, ST remains the leading cause of device failure. K E Y W O R D Saneurysm/dissection/perforation, complications, CORD-coronary, coronary artery disease, percutaneous coronary intervention, stent fracture/failure, stent thrombosis

show abstract

Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation

Cited by 44 publications

References 27 publications

Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new‐generation covered stents

Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new‐generation covered stents

Late lumen enlargement induced by drug coated balloon in the patient with PTFE‐covered stent restenosis

Acute and long‐term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3‐CAP registry

Contact Info

Product

Resources

About